The health crisis has not turned into an economic crisis for all. Oxfam said on Thursday that vaccines against Kovid-19 have enabled at least nine people to become billionaires. Among them, we especially find the French CEO of Moderna Stephen Bansell. Above all, the NGO notes a strong symbol: the cumulative fate of these new billionaires will make vaccination of the poorest countries possible.

In a press release published ahead of a World Summit on G20 health on Friday in Rome, Oxfam estimates that these new fortunes have emerged “thanks to the huge profits from pharmaceutical groups holding a monopoly on the production of vaccines against Kovid”.

These figures are based on the rankings of American magazines Forbes And is published by the “People’s Vaccine Alliance”, of which Oxfam is a member, bringing together organizations and personalities worldwide to apply free vaccines against Kovid. The cumulative fortune of nine billionaires, $ 19.3 billion, “will allow all low-income countries to be vaccinated 1.3 times”, which “have received only 0.2% of the vaccines produced in the world.”, Especially due to the lack of available doses ”, According to Oxfam.

For Oxfam, vaccines are “a global public good”

The first two fugitives, which stand apart from the crowd, are owned by CEO of Modern Stephen Bansell ($ 4.3 billion) and Ugur Sahin (4 billion), CEO and co-founder of BioNotech. The NGO states that eight other billionaires with “large portfolios of stocks” in pharmaceutical companies have experienced a cumulative increase of $ 32.2 billion in their wealth, which is “enough to immunize the entire Indian population”. “These vaccines were financed by public money and should be above all global public good,” said Sandra Lotte-Fernandes of Oxfam France, who called for an immediate end to these monopolies.

The European Commission on Wednesday assured that the European Union would be “constructive” in the WTO, which would assess the lifting of patents for anti-Kovid vaccines desired by Washington, but would first propose measures to speed up production. The day before, international organizations present at a summit on African economies held in Paris, along with African countries, European countries and other continents, requested to lift patents on anti-covid vaccines, to allow their production in Africa Was. But “key members of the G20, including the United Kingdom and Germany, continue to block initiatives to remove intellectual property-related barriers on vaccines”, condemning Oxfam, which also points towards France’s “ambiguous position” on the subject Indicates.